2016
DOI: 10.5812/ircmj.21584
|View full text |Cite
|
Sign up to set email alerts
|

Population-Based Preference Weights for the EQ-5D Health States Using the Visual Analogue Scale (VAS) in Iran

Abstract: BackgroundHealth-related quality of life (HRQoL) is used as a measure to valuate healthcare interventions and guide policy making. The EuroQol EQ-5D is a widely used generic preference-based instrument to measure Health-related quality of life.ObjectivesThe objective of this study was to develop a value set of the EQ-5D health states for an Iranian population.Patients and MethodsThis study is a cross-sectional study of Iranian populations. Our sample from Iranian populations consists out of 869 participants, w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
40
1

Year Published

2016
2016
2021
2021

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 39 publications
(47 citation statements)
references
References 30 publications
(43 reference statements)
3
40
1
Order By: Relevance
“…This study is supported by a previous study [16] showing that pain/discomfort was the most common health problem (34.4%) and that 33.4% of the population suffered from anxiety/depression in Tehran. Similar studies have shown that most problems in the general population related to the pain/discomfort and anxiety/depression dimensions of HRQoL.…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…This study is supported by a previous study [16] showing that pain/discomfort was the most common health problem (34.4%) and that 33.4% of the population suffered from anxiety/depression in Tehran. Similar studies have shown that most problems in the general population related to the pain/discomfort and anxiety/depression dimensions of HRQoL.…”
Section: Discussionsupporting
confidence: 89%
“…This study used the Iranian value set for EQ-5D health states in order to calculate participants’ QoL. This value set was derived using the visual analog scale method [16]. Socioeconomic variables are basic predictors of health and QoL [4,17].…”
Section: Methodsmentioning
confidence: 99%
“…The second part (EQ VAS) is a graded tool for health status where the respondents select a score from 0 to 100 to represent their level of health, with higher scores indicating better QoL. 15,22,23 Short Form Health Survey (SF-36) is another instrument used for assessing general health of β-thalassemia patients. This is also a general tool for measuring QoL in different contexts.…”
Section: Study Design and Subjectsmentioning
confidence: 99%
“…The other 10 studies used EQ-5D along with other kinds of methods or questionnaires, such as socio-demographic questionnaires, SF-36, TTO, VAS, DLQI, PASI, Type 2 Diabetes and Health Promotion Scale (T2DHPS). (Seyedifar et al, 2016, Karyani et al, 2016, Yousefi et al, 2016, Goudarzi et al, 2016, Assadi&Afshari, 2016, Javanbakht et al, 2015, Saffari et al, 2015, Hosseini Nejhad et al, 2013, Javanbakht et al, 2012 A cross-sectional analytical study was conducted by Karyani et al to measure HRQOL in Bthalassemia patients using ED-5D along with information about participants' demographic, socioeconomic, and health status was gathered. (Karyani et al, 2016) Another study also used ED-5D with information about participants' demographic in order to conduct their survey on patients with type 2 diabetes.…”
Section: International Comparison Of Hrqol Resultsmentioning
confidence: 99%
“…(Saffari et al, 2015) Six studies used Visual Analogue Scale (VAS) along with ED-5D including the paper we published. (Seyedifar et al, 2016, Goudarzi et al, 2016, Hosseini Nejhad et al, 2013, Javanbakht et al, 2012, Assadi&Afshari, 2016 (Yousefi et al, 2016) Another cross-sectional study, gathered data by using a socio-demographic questionnaire, EQ-5D, and SF-36 instruments on patients with β-thalassemia. (Javanbakht et al, 2015) Mean EQ-5D-3L index score in psoriasis patients was 0.62, which is lower than experienced by patients with type 2 diabetes (0.70), breast cancer (0.69) and beta thalassemia (0.86) patients In Iran (Table 32).…”
Section: International Comparison Of Hrqol Resultsmentioning
confidence: 99%